GJIA
GSK icon

Glass Jacobson Investment Advisors’s GSK GSK Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-141
Closed -$4.77K – 668
2025
Q1 		$4.77K Hold
141
– – ﹤0.01% 674
2024
Q4 		$4.77K Buy
141
+109
+341% +$3.92K ﹤0.01% 674
2024
Q3 		$1.31K Hold
32
– – ﹤0.01% 706
2024
Q2 		$1.23K Hold
32
– – ﹤0.01% 698
2024
Q1 		$1.37K Hold
32
– – ﹤0.01% 695
2023
Q4 		$1.19K Hold
32
– – ﹤0.01% 669
2023
Q3 		$1.16K Hold
32
– – ﹤0.01% 687
2023
Q2 		$1.14K Buy
+32
New +$1.15K ﹤0.01% 692
2022
Q4 		$2.67K Buy
+76
New +$2.53K ﹤0.01% 645

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Glass Jacobson Investment Advisors's GSK Position: Q2 2025 in Review

Glass Jacobson Investment Advisors sold out of GSK (GSK) in Q2 2025, closing a stake of 141 shares — an estimated $4.77K sold.

Glass Jacobson Investment Advisors first reported a position in GSK in Q4 2022 and held it in 9 quarters. The position peaked at $4.77K in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Glass Jacobson Investment Advisors reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 141 GSK shares in Q2 2025, an estimated $4.77K.
  • Glass Jacobson Investment Advisors first reported a position in GSK in Q4 2022 and held it in 9 quarters.
  • Glass Jacobson Investment Advisors's GSK position peaked at $4.77K in Q1 2025.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.